- Home
- SEPN vs BDN Comparison
SEPN vs BDN Comparison
Compare SEPN & BDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SEPN
- BDN
- Stock Information
- Founded
- SEPN 2022
- BDN 1986
- Country
- SEPN United States
- BDN United States
- Employees
- SEPN N/A
- BDN N/A
- Industry
- SEPN
- BDN Real Estate Investment Trusts
- Sector
- SEPN
- BDN Real Estate
- Exchange
- SEPN NYSE
- BDN Nasdaq
- Market Cap
- SEPN 1.0B
- BDN 894.4M
- IPO Year
- SEPN 2024
- BDN N/A
- Fundamental
- Price
- SEPN $22.53
- BDN $5.21
- Analyst Decision
- SEPN
- BDN Buy
- Analyst Count
- SEPN 0
- BDN 3
- Target Price
- SEPN N/A
- BDN $5.83
- AVG Volume (30 Days)
- SEPN 399.2K
- BDN 2.2M
- Earning Date
- SEPN 11-26-2024
- BDN 10-22-2024
- Dividend Yield
- SEPN N/A
- BDN 11.54%
- EPS Growth
- SEPN N/A
- BDN N/A
- EPS
- SEPN N/A
- BDN N/A
- Revenue
- SEPN $838,000.00
- BDN $306,926,000.00
- Revenue This Year
- SEPN N/A
- BDN N/A
- Revenue Next Year
- SEPN N/A
- BDN $2.29
- P/E Ratio
- SEPN N/A
- BDN N/A
- Revenue Growth
- SEPN N/A
- BDN N/A
- 52 Week Low
- SEPN $18.62
- BDN $3.85
- 52 Week High
- SEPN $26.34
- BDN $6.54
- Technical
- Relative Strength Index (RSI)
- SEPN N/A
- BDN 41.92
- Support Level
- SEPN N/A
- BDN $5.19
- Resistance Level
- SEPN N/A
- BDN $5.32
- Average True Range (ATR)
- SEPN 0.00
- BDN 0.16
- MACD
- SEPN 0.00
- BDN -0.02
- Stochastic Oscillator
- SEPN 0.00
- BDN 32.69
About SEPN SEPTERNA INC
Septerna Inc is a clinical-stage biotechnology company pioneering a new era of G protein-coupled receptor (GPCR) oral small molecule drug discovery powered by a proprietary Native Complex Platform. Its industrial-scale platform aims to unlock the full potential of GPCR therapies. The group discovery and development of a pipeline of product candidates focused initially on treating patients in three therapeutic areas: endocrinology, immunology and inflammation, and metabolic disease. Its pipeline includes SEP-786 (PTH1R), SEP-631 (MRGPRX2), TSHR, and GLP-1R, GIPR, GCGR.
About BDN Brandywine Realty Trust
Brandywine Realty Trust engaged in the acquisition, development, redevelopment, ownership, management, and operation of a portfolio of office, life science/lab, residential, and mixed-use properties. The company owned and managed properties within five segments. The Philadelphia CBD segment includes properties located in the City of Philadelphia in Pennsylvania. The Pennsylvania Suburbs segment includes properties in Chester, Delaware and Montgomery counties in the Philadelphia suburbs. The Austin, Texas segment includes properties in the City of Austin, Texas. The Metropolitan Washington, D.C. segment includes properties in Northern Virginia, Washington, D.C. and Southern Maryland. The Other segment includes properties in Camden County, New Jersey and New Castle County, Delaware.